Skip to content
DataLookout
Menu

NCT05932914

Liver Biopsy Following Gene Therapy For Hemophilia

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 30 versions: 29 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Minor Start date pushed from Oct 2026 to Nov 2026
  2. Notable Eligibility criteria expanded, about 12 words
    • Start date: Sep 2026 to Oct 2026
    • Secondary endpoints: details revised at 1 of 5 entries
    • Site details revised
  3. Minor Start date: Aug 2026 to Sep 2026v28
  4. Minor Start date: Jul 2026 to Aug 2026v27
  5. Minor Start date: Jun 2026 to Jul 2026v26
Show 23 earlier versionsHide 23 earlier versions
  1. Minor Start date: May 2026 to Jun 2026
    • Site contact updated
    v25
  2. Notable Start date: Mar 2026 to May 2026v24
  3. Minor Start date: Feb 2026 to Mar 2026v23
  4. Minor Start date: Jan 2026 to Feb 2026v22
  5. Notable Start date: Nov 2025 to Jan 2026v21
  6. Minor Start date: Oct 2025 to Nov 2025v20
  7. Notable Primary and study completion dates: May 2026 to Jan 2030v19 Show 4 more changesShow less
    • Start date: Aug 2025 to Oct 2025
    • Eligibility criteria expanded, about 28 words
    • Study description expanded, about 28 words
    • Collaborators expanded, about 3 words
  8. Notable Start date: May 2025 to Aug 2025v18
  9. Notable Primary and study completion dates: May 2025 to May 2026
    • Start date: Mar 2025 to May 2025
    v17
  10. Minor Start date: Jan 2025 to Mar 2025v16
  11. Notable Start date: Oct 2024 to Jan 2025v15
  12. Notable Start date: Jul 2024 to Oct 2024v14
  13. Minor Start date: Jun 2024 to Jul 2024v13
  14. Minor Start date: May 2024 to Jun 2024v12
  15. Minor Start date: Apr 2024 to May 2024v11
  16. Minor Start date: Mar 2024 to Apr 2024v10
  17. Minor Start date: Feb 2024 to Mar 2024v9
  18. Minor Start date: Jan 2024 to Feb 2024v8
  19. Minor Start date: Dec 2023 to Jan 2024v7
  20. Minor Start date: Nov 2023 to Dec 2023v6
  21. Minor Start date: Oct 2023 to Nov 2023v4
  22. Minor Start date: Sep 2023 to Oct 2023v3
  23. Notable Start date: Jul 2023 to Sep 2023v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Assessment of the number of hepatocytes transduced with AAV vector genome in liver biopsy samples analyzed by FISH
Timeframe: single time point (day of biopsy)

Secondary (5)

The degree of hepatocyte damage at a morphological level
The number and type of hot spots for integration of AAV provirus in liver cells
The number of hepatocytes revealing FVIII/FIX RNA in-situ transcripts
The number and types of epigenetic changes within the AAV genome in the liver
The qualitative and quantitative assessment of the RNA transcriptome

Arms and interventions

Participants

Those who meet the Eligibility Criteria

Procedures: Liver Biopsy

Sites

1 site in 1 country

  • St. Jude Children's Research HospitalMemphis, Tennessee, United States